Viewing Study NCT05854966


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-01-27 @ 2:53 PM
Study NCT ID: NCT05854966
Status: WITHDRAWN
Last Update Posted: 2024-09-19
First Post: 2023-05-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Sponsor: Wake Forest University Health Sciences
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: WFBCCC 22323
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View
None INDUSTRY View